Skip to content

A clinical comparative study between midazolam and tramadol when given as intrathecal adjuvants to hyperbaric bupivacaine for patients undergoing infraumbilical surgeries.

A Clinical Comparative study between intrathecal midazolam and tramadol with 0.5% hyperbaric bupivacaine for patients undergoing infraumbilical surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031133
Enrollment
70
Registered
2021-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K35-K38- Diseases of appendix Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 3: K40-K46- Hernia

Interventions

Intervention1: Intrathecal adjuvants Tramadol comparison with midalzolam: Dose of tramadol 25mg.To evaluate the onset and duration of sensory and motor blockade and to evaluate the effectiveness of po

Sponsors

Mashabi Nadaf
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 and 2 of either sex scheduled for infraumbilical surgeries

Exclusion criteria

Exclusion criteria: Gross spinal deformities History of perineural neuropathy Sepsis at site of infection Coagulopathy History of allergies to LA and opiods Emergency cases Pregnant and lactating females

Design outcomes

Primary

MeasureTime frame
Clinical comparative study between intrathecal adjuvants midazolam and tramadol with 0.5% hyperbaric bupivacaine in Infraumbilical surgeries to evaluate onset and duration of sensory and motor blockade.Timepoint: From the onset of spinal anaesthesia action till the use of first rescue analgesia.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDrMashabi J Nadaf

Kempegowda institute of medical science and research hospital

ambunagaraj67@gmail.com9480383382

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026